Cargando…

The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis

BACKGROUND: Knee osteoarthritis (KOA) is a common disabling disease. Limited studies have demonstrated that prolotherapy with dextrose or with prolozone can be helpful in the treatment of patients with KOA. OBJECTIVES: In the current study, we compared the results between these two treatment methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemi, Masoud, Jalili, Parviz, Mennati, Shirin, Koosha, Alireza, Rohanifar, Ramin, Madadi, Firouz, Razavi, Seyed Sajad, Taheri, Farinaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644302/
https://www.ncbi.nlm.nih.gov/pubmed/26587401
http://dx.doi.org/10.5812/aapm.27585
_version_ 1782400652288196608
author Hashemi, Masoud
Jalili, Parviz
Mennati, Shirin
Koosha, Alireza
Rohanifar, Ramin
Madadi, Firouz
Razavi, Seyed Sajad
Taheri, Farinaz
author_facet Hashemi, Masoud
Jalili, Parviz
Mennati, Shirin
Koosha, Alireza
Rohanifar, Ramin
Madadi, Firouz
Razavi, Seyed Sajad
Taheri, Farinaz
author_sort Hashemi, Masoud
collection PubMed
description BACKGROUND: Knee osteoarthritis (KOA) is a common disabling disease. Limited studies have demonstrated that prolotherapy with dextrose or with prolozone can be helpful in the treatment of patients with KOA. OBJECTIVES: In the current study, we compared the results between these two treatment methods. PATIENTS AND METHODS: In the current randomized clinical trial, 80 patients with mild to moderate KOA were randomly assigned equally into two groups (ozone group and dextrose group). In each group, injections were repeated three times with 10-day intervals. Before the treatment and 3 months after the injections, the pain intensity was measured by using a visual analogue scale and the Western Ontario and McMaster university arthritis index scores. Finally, the results were compared between the two groups. RESULTS: In the two groups, the pain intensity and WOMAC scores significantly decreased and increased, respectively (P < 0.001). However, there was no significant difference between the two groups. CONCLUSIONS: Prolotherapy with dextrose and with prolozone result in the same pain relief or functional improvement in patients with mild to moderate KOA.
format Online
Article
Text
id pubmed-4644302
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-46443022015-11-19 The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis Hashemi, Masoud Jalili, Parviz Mennati, Shirin Koosha, Alireza Rohanifar, Ramin Madadi, Firouz Razavi, Seyed Sajad Taheri, Farinaz Anesth Pain Med Research Article BACKGROUND: Knee osteoarthritis (KOA) is a common disabling disease. Limited studies have demonstrated that prolotherapy with dextrose or with prolozone can be helpful in the treatment of patients with KOA. OBJECTIVES: In the current study, we compared the results between these two treatment methods. PATIENTS AND METHODS: In the current randomized clinical trial, 80 patients with mild to moderate KOA were randomly assigned equally into two groups (ozone group and dextrose group). In each group, injections were repeated three times with 10-day intervals. Before the treatment and 3 months after the injections, the pain intensity was measured by using a visual analogue scale and the Western Ontario and McMaster university arthritis index scores. Finally, the results were compared between the two groups. RESULTS: In the two groups, the pain intensity and WOMAC scores significantly decreased and increased, respectively (P < 0.001). However, there was no significant difference between the two groups. CONCLUSIONS: Prolotherapy with dextrose and with prolozone result in the same pain relief or functional improvement in patients with mild to moderate KOA. Kowsar 2015-10-17 /pmc/articles/PMC4644302/ /pubmed/26587401 http://dx.doi.org/10.5812/aapm.27585 Text en Copyright © 2015, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Hashemi, Masoud
Jalili, Parviz
Mennati, Shirin
Koosha, Alireza
Rohanifar, Ramin
Madadi, Firouz
Razavi, Seyed Sajad
Taheri, Farinaz
The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis
title The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis
title_full The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis
title_fullStr The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis
title_full_unstemmed The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis
title_short The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis
title_sort effects of prolotherapy with hypertonic dextrose versus prolozone (intraarticular ozone) in patients with knee osteoarthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644302/
https://www.ncbi.nlm.nih.gov/pubmed/26587401
http://dx.doi.org/10.5812/aapm.27585
work_keys_str_mv AT hashemimasoud theeffectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT jaliliparviz theeffectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT mennatishirin theeffectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT kooshaalireza theeffectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT rohanifarramin theeffectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT madadifirouz theeffectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT razaviseyedsajad theeffectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT taherifarinaz theeffectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT hashemimasoud effectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT jaliliparviz effectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT mennatishirin effectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT kooshaalireza effectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT rohanifarramin effectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT madadifirouz effectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT razaviseyedsajad effectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis
AT taherifarinaz effectsofprolotherapywithhypertonicdextroseversusprolozoneintraarticularozoneinpatientswithkneeosteoarthritis